Recombinant human soluble thrombomodulin and short-term mortality of infection patients with disseminated intravascular coagulation: a meta-analysis
Several studies have demonstrated that recombinant human soluble thrombomodulin (rhTM) has potential advantages for the treatment for patients with infection complicated by disseminated intravascular coagulation (DIC). However, whether injection of rhTMc
Several studies have demonstrated that Recombinant human soluble thrombomodulin (rhTM) has potential advantages for the treatment for patients with infection complicated by disseminated intravascular coagulation (DIC).However, whether injection of rhTMcan affect themortality of those patients in clinical treatment remains controversial.Therefore, we conducted ameta-analysis to evaluate the clinical efficacy for patientswith infection complicated by DIC.
相关文章
评论
我要跟帖
.jpg)
